Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02232009 · ClinicalTrials.gov registry record · NA
Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit
A NA study, sponsored by GE Healthcare.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02232009 is a NA study that was terminated before completion, run by GE Healthcare. The registered enrollment target is 9 participants.
The verdict
NCT02232009, a NA study, was terminated before completion, sponsored by GE Healthcare.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study investigates a novel magnetic resonance imaging (MRI) system designed by GEHC for imaging viable neonate and infant populations. This MR system has a smaller size and design features that may make it more feasible to locate the system in close proximity to care areas for neonates (birth - 1 month) and infants (less than 1 month to two years), such as clinical neonatal intensive care units (NICUs) and other infant and neonatal care departments.
Interventions
- DEVICE 3.0 T Neonatal MRI Scanner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-05-07 |
| Est. Completion | 2016-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02232009
The ClinicalTrials.gov registry entry for NCT02232009 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 3.0 T Neonatal MRI Scanner is the first listed.
NCT02232009 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02232009 about?
NCT02232009 is a clinical study titled "Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit". This study investigates a novel magnetic resonance imaging (MRI) system designed by GEHC for imaging viable neonate and infant populations. This MR system has a smaller size and design features that may make it more feasible to locate the system in close proximity to care areas for neonates (birth -...
What is the current status of trial NCT02232009?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2015-05-07. Estimated completion is 2016-11-30.
What interventions are being tested in trial NCT02232009?
The interventions under investigation include: 3.0 T Neonatal MRI Scanner (DEVICE).
Who is sponsoring clinical trial NCT02232009?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.